[ad_1]
WASHINGTON D.C. [USA]: According to a new study, a low-dose aspirin regimen may represent a new avenue for reducing the pathology of Alzheimer's disease.
A study by the Society for Neuroscience showed that the clearance of toxic beta-amyloids, particularly the hippocampus, is a major mechanism.
The activation of the cellular machinery responsible for eliminating brain waste has therefore become a promising strategy for slowing down the disease.
Alzheimer's disease is a life-threatening form of dementia that affects people 65 years of age and older.